More importantly, cytotoxicity indicators (GZMB, IFN‐γ, TNF‐α, and Perforin) of CTLs were also reinforced in murine tumor with BCAT2 loss and combination treatment compared to corresponding control (Figure 6G,I–L). This evidence concerns the gene PRF1 and neoplasm.